Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement, Reshef A, Kidon M, Leibovich I. The Story of Angioedema: from Quincke to Bradykinin, vol.24, pp.121-160, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01813353
Concerning the acute localized oedema of the skin, Mschr Prakt Dermatol, vol.1882, pp.160-169 ,
Uber acutes (angioneurotisches) Odem, Zeitschr F Klin Med, vol.9, p.381, 1995. ,
Hereditary angio-neurotic oedema, Am J Med Sci, vol.95, pp.362-369, 1888. ,
Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update, Allergy, vol.7, pp.1575-1596, 2018. ,
, J Am Acad Dermatol, vol.53, pp.373-88, 2005.
Epidemiology of urticaria: a representative cross-sectional population survey, Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M. Epidemiology of Bradykininmediated angioedema: a systematic investigation of epidemiological studies, vol.19, p.50, 2005. ,
Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry, Orphanet J Rare Dis, vol.13, p.73, 2018. ,
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency, Int Arch Allergy Immunol, vol.164, pp.300-313, 2000. ,
Black Americans have an increased rate of angiotensin convertase inhibitor-associated angioedema, Boccon-Gibod I, Bouillet L. Angioedema and urticaria, vol.19, pp.650-654, 1990. ,
, Immunol Allergy Clin North Am, vol.3, pp.467-481, 2017.
Classification of anti-Fc!RI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity, Mathelier-Fusade P, Vermeulen C, Leynadier F. Responsibility of food in exercise-induced anaphylaxis: 7 cases, vol.44, pp.958-961, 1999. ,
Immunologic contact urticaria, Immunol Allergy Clin North Am, vol.34, pp.157-67, 2014. ,
, Clinicoepidemiologic Features of Chronic Urticaria in Patients with versus without
The EAACI/GA/LEN/EDF/WAO guideline for the definition, classification, diagnosis, and ma-nagement of urticaria: the 2013 revision and update, Subclinical Helicobacter pylori Infection: A Cross-Sectional Study of 150 Patients, vol.175, pp.330-371, 1962. ,
A biochemical abnormality in hereditary angioneurotic edema : absence of serum inhibitor of C'1-esterase, SERPING1 mutations in 59 families with hereditary angioedema, vol.35, pp.18-27, 1963. ,
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1esterase inhibitor deficiency workshop and beyond, Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema, vol.106, pp.2273-2280, 2000. ,
Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant, Ponard D. Hereditary angioedema biological diagnosis, vol.54, pp.274-81, 2003. ,
,
An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema, Clin Exp Immunol, vol.44, p.70140, 2007. ,
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency, Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P, vol.121, pp.308-320, 2008. ,
, , 2010.
A systematic review of the literature of the three related disease entities cheilitis granulomatosa, orofacial granulomatosis and Melkersson-Rosenthal syndrome, Launay D. Angioedema: differential diagnosis, vol.6, pp.1493-1502, 1985. ,
Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria, J Eur Acad Dermatol Venereol, vol.115, pp.365-72, 2000. ,
Multiple mechanisms of inhibition of IgE-and mast cell-dependent cutaneous inflammation in the mouse, J Immunol, vol.154, pp.1391-1399, 1995. ,
Treatment of Refractory Chronic Spontaneous Urticaria with Adalimumab, Rituximab in Refractory Chronic Spontaneous Urticaria: An Encouraging Therapeutic Approach, vol.129, pp.524-525, 2017. ,
A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1, Skin Pharmacol Physiol, vol.31, pp.184-187, 2018. ,
, antihistamine-resistant chronic spontaneous urticaria, Indian J Dermatol Venereol Leprol, vol.80, pp.122-130, 2014.
,
Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence, J Allergy Clin Immunol, vol.141, pp.638-649, 2018. ,
Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial, J Allergy Clin Immunol, vol.140, pp.931-932, 2010. ,
Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy, Allergy, vol.63, pp.247-249, 2008. ,
Efficacy of omalizumab in delayed pressure urticaria: a case report, Allergy, vol.63, pp.138-139, 2008. ,
Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: A pilot study, J Allergy Clin Immunol, vol.140, pp.302-305, 2008. ,
Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis ,
, Br J Dermatol, vol.166, pp.1373-1374, 2012.
Breh-ler R. Delayed pressure urticariadapsone heading for first-line therapy?, J Allergy Clin Immunol, vol.119, pp.908-912, 2000. ,
Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study, Edstrom DW, Ros AM. Cyclosporin A therapy for severe solar urticaria, vol.71, pp.948-953, 2014. ,
Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and metaanalysis, Photoder-matol Photoimmunol Photomed, vol.13, pp.775-788, 1997. ,
Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®), Ann Allergy Asthma Immunol, vol.135, pp.149-54, 2010. ,
C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency, Farkas H, Varga L. Human Plasma-Derived, Nanofiltered, vol.13, pp.109-123, 2012. ,
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study, Gelfand JA, vol.119, pp.281-288, 1976. ,
Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients, Clin Exp Immunol, vol.7, pp.112-119, 2014. ,
The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women, A random double-blind cross-over study, vol.192, pp.1034-1039, 1972. ,
175 : Farkas H. Pharmacological Management of Hereditary Angioedema with C1Inhibitor Deficiency in Pediatric Patients, J Investig Allergol Clin Immunol, vol.23, pp.135-151, 2013. ,
Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant, Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema, vol.5, pp.29-36, 2014. ,
Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema, Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema. Allergy Asthma Proc, vol.38, pp.520-524, 2011. ,
, Management of angiotensin-converting enzyme inhibitor-related angioedema: Recommendations from the French national centre for angioedema, Rev Med Interne, vol.34, pp.209-222, 2013.
The use of plasma-derived complement C1-esterase inhibitor concentrate (Berinert) in the treatment of angiotensin converting enzyme-inhibitor related angioedema, Angiotensinconverting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal, vol.3, pp.429-462, 2011. ,
Successful treatment of refractory idiopathic angioedema with omalizumab: review of the literature and function of IgE in angioedema, J Investig Allergol Clin Immunol, vol.108, pp.399-402, 2012. ,
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency, J Allergy Clin Immunol, vol.37, pp.692-697, 2012. ,
High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria, J Eur Acad Dermatol Venereol, vol.22, pp.557-61, 2003. ,
, Annexe 3 : score d'activité de l'urticaire sur 7 jours
,
, Annexe 6 : Questionnaire de qualité de vie de l'urticaire chronique
,
, Poids : Dès les premiers signes, appeler le SAMU (15 ou 112 sur portable), pratiquer le protocole suivant et prévenir les parents : Noter la date, l'heure des signes et des médicaments donnés
, Annexe 14 : lettre d'information médecin traitant, angio-oedème histaminique Patient
est sujet(te) à des angio-oedèmes histaminiques de type, Votre patient(e) ,
Un oedème localisé, sans signe d'anaphylaxie, associée ou non à une urticaire superficielle, nécessitera la prise d'un comprimé d'antihistaminique ,
,
, En cas de signe d'anaphylaxie (! grade 2) et / ou d'angio-oedème des
,
Je reste à votre disposition pour tout renseignement complémentaire. Veuillez agréer, cher confrère, l'expression de mes salutations distinguées ,